The FDA just issued new guidance on the MRI compatibility--or in some cases incompatibility--of implants that do not require electrical power to service their function, such as cardiovascular stents, intracranial aneurysm clips, endovascular grafts and transprostatic tissue retractors.
Some patients with cochlear implants feel pain during an MRI that is strong enough to prevent them from completing the procedure, a recent study in the Journal of the American Medical Association shows.
Flowonix, maker of the implantable Prometra infusion pump for chronic pain patients, announced that it has raised $40 million in debt and equity financing led by private equity fund Élevage Capital Management.
President Obama's trip to China was a productive one. Not to be overshadowed by the countries' new climate change accord is an agreement to expand the World Trade Organization's tariff-cutting Information Technology Agreement, to include a host of new products, including medical devices.
Pending FDA approval, the upgraded Prometra Implantable Pump System for targeted drug delivery of pain medication will feature MRI compatibility, Flowonix CEO Steve Adler told FierceDrugDelivery in an interview.
Both GE Healthcare and the FBI are accusing a Chinese engineer of stealing millions of files of trade secrets from a maker of magnetic resonance imaging machines and related diagnostic equipment.
Physicians have long implemented magnetic resonance imaging (MRI) as a way to diagnose traumatic brain injury, but a new spin on the technology could help doctors assess injury sooner.
The Institute of Cancer Research, London, became the latest member of a consortium seeking to integrate magnetic resonance imaging into radiation therapy.
GE Healthcare and MRI software provider CorTechs Labs signed a joint-marketing agreement on a MRI scanning solution used in conjunction with CorTech's NeuroQuant program.
Medtronic's Evera MRI SureScan cardioverter-defibrillator was implanted for the first time in the U.S. as part of the product's 275-patient, 45-center pivotal clinical trial for FDA approval.